Federated Hermes
EOLS icon

Federated Hermes’s Evolus EOLS Stock Holding History

Federated Hermes’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-99
Closed -$1.19K – 2098
2025
Q1 		$1.19K Buy
+99
New +$1.29K ﹤0.01% 1988
2024
Q2 		– Sell
-32,319
Closed -$452K – 2048
2024
Q1 		$452K Buy
32,319
+32,277
+76,850% +$419K ﹤0.01% 1348
2023
Q4 		$442 Buy
+42
New +$376 ﹤0.01% 2015
2022
Q2 		– Sell
-32,446
Closed -$364K – 2192
2022
Q1 		$364K Sell
32,446
-128,589
-80% -$1.1M ﹤0.01% 1514
2021
Q4 		$1.05M Sell
161,035
-135
-0.1% -$926 ﹤0.01% 1260
2021
Q3 		$1.23M Buy
161,170
+9,058
+6% +$93.7K ﹤0.01% 1209
2021
Q2 		$1.92M Buy
152,112
+114,360
+303% +$1.26M ﹤0.01% 1112
2021
Q1 		$490K Buy
+37,752
New +$348K ﹤0.01% 1567
2019
Q1 		– Sell
-541
Closed -$6K – 2167
2018
Q4 		$6K Sell
541
-58
-10% -$827 ﹤0.01% 1947
2018
Q3 		$11K Buy
+599
New +$13K ﹤0.01% 1940

Other funds holding EOLS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Federated Hermes's EOLS Position: Q2 2025 in Review

Federated Hermes sold out of Evolus (EOLS) in Q2 2025, closing a stake of 99 shares — an estimated $1.19K sold.

Federated Hermes first reported a position in EOLS in Q3 2018 and held it in 10 quarters. The position peaked at $1.92M in Q2 2021. 172 funds tracked by Wall St. Rank hold EOLS as of Q2 2025.

  • Federated Hermes reported no remaining Evolus position as of Q2 2025 after selling out during the quarter.
  • Federated Hermes sold 99 Evolus shares in Q2 2025, an estimated $1.19K.
  • Federated Hermes first reported a position in Evolus in Q3 2018 and held it in 10 quarters.
  • Federated Hermes's Evolus position peaked at $1.92M in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Evolus as of Q2 2025.

Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.